13.5.3: Drugs affecting the immune response

Part of chapter 13 Skin, section 13.5 Preparations for eczema and psoriasis

High-level prescribing trends for Drugs affecting the immune response (BNF section 13.5.3) across Hyde PCN for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Brodalumab (Psoriasis) (1305030E0)
Efalizumab (1305030A0)
Guselkumab (Psoriasis) (1305030F0)
Ixekizumab (1305030G0)
Pimecrolimus (1305030B0)
Tacrolimus (1305030C0)
Tildrakizumab (1305030H0)
Ustekinumab (Psoriasis) (1305030D0)
Feedback